ingelvac circoflex suspension for injection in pigs
boehringer ingelheim animal health australia pty. ltd. - porcine circovirus type 2 orf2 protein; carbomer - misc. vaccines or anti sera - porcine circovirus type 2 orf2 protein vaccine-viral active 1.0 ml/do; carbomer ungrouped other 1.0 mg - immunotherapy - pigs - see label for type - disease control
hypurin porcine 30/70 mix 100units/ml suspension for injection 1.5ml cartridges
c p pharmaceuticals ltd - insulin soluble porcine; insulin isophane porcine - suspension for injection - 30unit/1ml ; 70unit/1ml
porcine parvovirus
intervet australia pty limited - porcine parvo virus - unknown - porcine parvo virus vaccine-viral active 0.0 - active constituent
porcine parvovirus - inactivated
zoetis australia pty ltd - porcine parvo virus - unknown - porcine parvo virus vaccine-viral active 0.0 - active constituent
porcine circovirus type 2 orf2 protein
boehringer ingelheim animal health australia pty. ltd. - porcine circovirus type 2 orf2 protein - unknown - porcine circovirus type 2 orf2 protein vaccine-viral active 0.0 - active constituent
adriamycin doxorubicin hydrochloride 50mg/25ml injection vial
pfizer australia pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - adriamycin has been used successfully to produce regression in neoplastic conditions such as: acute leukaemia, wilms' tumour, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, lymphomas of both hodgkin's and non-hodgkin's type, bronchogenic (lung) carcinoma, thyroid carcinoma, hepatomas, ovarian carcinoma, etc. the main antitumour activities are listed in table 1 of the product information. adriamycin is also indicated by intravesical administration in the primary management of non-metastatic carcinoma of the bladder. (tis, t1, t2).
adriamycin doxorubicin hydrochloride 20mg/10ml injection vial
pfizer australia pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - adriamycin has been used successfully to produce regression in neoplastic conditions such as: acute leukaemia, wilms' tumour, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, lymphomas of both hodgkin's and non-hodgkin's type, bronchogenic (lung) carcinoma, thyroid carcinoma, hepatomas, ovarian carcinoma, etc. the main antitumour activities are listed in table 1 of the product information. adriamycin is also indicated by intravesical administration in the primary management of non-metastatic carcinoma of the bladder. (tis, t1, t2).
adriamycin doxorubicin hydrochloride 10mg/5ml injection vial
pfizer australia pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - adriamycin has been used successfully to produce regression in neoplastic conditions such as: acute leukaemia, wilms' tumour, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, lymphomas of both hodgkin's and non-hodgkin's type, bronchogenic (lung) carcinoma, thyroid carcinoma, hepatomas, ovarian carcinoma, etc. the main antitumour activities are listed in table 1 of the product information. adriamycin is also indicated by intravesical administration in the primary management of non-metastatic carcinoma of the bladder. (tis, t1, t2).
porcine circovirus type 1-type 2b chimera inactivated
zoetis australia pty ltd - porcine circovirus type 1-type 2b chimera inactivated - unknown - porcine circovirus type 1-type 2b chimera inactivated vaccine-antigen/antibody active 0.0 - active constituent
cirbloc inj. emuls. i.m. vial
ceva santé animale sa-nv - porcine circovirus 2 (inactivated) - emulsion for injection - porcine circovirus type 2, inactivated (pcv2) - porcine circovirus - pig